ScholarIQanswers from OpenAlex

Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy

PaperCitations, authors & open-access status

Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy have?

ScholarIQcitation count

Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy has 117 citations in the OpenAlex counts ScholarIQ stores.

When was Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy published?

ScholarIQyear

Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy has 2015 year in the ScholarIQ index.

What is the open-access status of Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy?

ScholarIQoa status

Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy has closed oa status in the ScholarIQ index.

What is the DOI of Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy?

ScholarIQdoi

The DOI for Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy is on the source record.

What is the PMID of Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy?

ScholarIQpmid

The PMID for Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy is on the source record.

What is the OpenAlex record for Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy?

ScholarIQopenalex

The OpenAlex for Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial